<?xml version="1.0" encoding="UTF-8"?>
<xml>
  <records>
    <record>
      <source-app name="Horizon">Horizon</source-app>
      <rec-number>1</rec-number>
      <foreign-keys>
        <key app="Horizon" db-id="fdi:010035770">1</key>
      </foreign-keys>
      <ref-type name="Journal Article">17</ref-type>
      <work-type>ACL : Articles dans des revues avec comité de lecture répertoriées par l'AERES</work-type>
      <contributors>
        <authors>
          <author>
            <style face="normal" font="default" size="100%">Njai, H. F.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Gali, Y.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Vanham, G.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Clybergh, C.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Jennes, W.</style>
          </author>
          <author>
            <style face="bold" font="default" size="100%">Vidal, Nicole</style>
          </author>
          <author>
            <style face="bold" font="default" size="100%">Butel, Christelle</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Mpoudi Ngolé, E.</style>
          </author>
          <author>
            <style face="bold" font="default" size="100%">Peeters, Martine</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Arien, K. K.</style>
          </author>
        </authors>
      </contributors>
      <titles>
        <title>The predominance of Human Immunodeficiency Virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness</title>
        <secondary-title>Retrovirology</secondary-title>
      </titles>
      <pages>art. no. 40 - NIL_1-NIL_11</pages>
      <dates>
        <year>2006</year>
      </dates>
      <call-num>fdi:010035770</call-num>
      <language>ENG</language>
      <periodical>
        <full-title>Retrovirology</full-title>
      </periodical>
      <isbn>1742-4690</isbn>
      <accession-num>CC:0002395051-0001</accession-num>
      <electronic-resource-num>10.1186/1742-4690-3-40</electronic-resource-num>
      <urls>
        <related-urls>
          <url>https://www.documentation.ird.fr/hor/fdi:010035770</url>
        </related-urls>
        <pdf-urls>
          <url>https://horizon.documentation.ird.fr/exl-doc/pleins_textes/2025-01/010035770.pdf</url>
        </pdf-urls>
      </urls>
      <volume>3</volume>
      <remote-database-provider>Horizon (IRD)</remote-database-provider>
      <abstract>Background: CRF02_AG is the predominant HIV strain circulating in West and West Central Africa. The aim of this study was to test whether this predominance is associated with a higher in vitro replicative fitness relative to parental subtype A and G viruses. Primary HIV-I isolates (10 CRF02_AG, 5 subtype A and 5 subtype G) were obtained from a well-described Cameroonian cohort. Growth competition experiments were carried out at equal multiplicity of infection in activated T cells and monocyte-derived dendritic cells (MO-DC) in parallel. Results: Dual infection/ competition experiments in activated T cells clearly indicated that CRF02_AG isolates had a significant replication advantage over the subtype A and subtype G viruses. The higher fitness of CRF02_AG was evident for isolates from patients with CD4+ T cell counts &gt; 200 cells/mu L (non-AIDS) or CD4+ T cell counts &lt; 200 cells/mu L (AIDS), and was independent of the co-receptor tropism. In MO-DC cultures, CRF02_AG isolates showed a slightly but not significantly higher replication advantage compared to subtype A or G isolates. Conclusion: We observed a higher ex vivo replicative fitness of CRF02_AG isolates compared to subtype A and G viruses from the same geographic region and showed that this was independent of the co-receptor tropism and irrespective of high or low CD4+ T cell count. This advantage in replicative fitness may contribute to the dominant spread of CRF02_AG over A and G subtypes in West and West Central Africa.</abstract>
      <custom6>052</custom6>
    </record>
  </records>
</xml>
